The biotech will present additional data for one of its pipeline candidates later this week.
News & Analysis: VBI Vaccines
Investors who are looking for promising coronavirus vaccine stocks should keep an eye out for this emerging biotech.
Pre-clinical results indicate that both are effective in only single doses.
Investors are fired up about an analyst's enthusiastic upgrade of the biotech stock.
The potential rewards with this biotech stock are high, but so are the risks.
If you're hoping this biotech will win big with its coronavirus vaccine candidate, you may be looking in the wrong place.
One of these biotechs appears to have an edge over the other.
One biotech keeps making headlines, the other's much quieter. But both have been big gainers, and both have strong potential opportunities.
A sell-off that began last week continues.
There's more to these small biotechs than just their coronavirus vaccine programs.